Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07801066
PHASE4

Testing Healthy Participants for Drowsiness After Single Dosing of Two Different Doses of Muscle Relaxer

Sponsor: Primus Pharmaceuticals

View on ClinicalTrials.gov

Summary

Health participants take a single dose, perform testing, washout for one week, take a single dose of different formulation, and perform testing for comparison of the 2 doses.

Official title: A Prospective, Randomized, Single-blind, Study to Assess Drowsiness, Cognition, Fall Risk, and Electroencephalographic (EEG) Dynamics After Oral Metaxalone Tablets 640 mg (M640) Versus Metaxalone 800 mg in Healthy Participants

Key Details

Gender

All

Age Range

18 Years - 55 Years

Study Type

INTERVENTIONAL

Enrollment

20

Start Date

2026-09-15

Completion Date

2027-01-15

Last Updated

2026-10-16

Healthy Volunteers

Yes

Interventions

DRUG

Metaxalone 640 mg

Dose micronized 640 mg

DRUG

Metaxalone 800 MG

The dose is 800 mg

Locations (1)

AMR Clinical - Columbus

Columbus, Ohio, United States